No data available
IONTAS is a privately owned, profitable, biotechnology company, offering services and technologies to the global biotechnology community. Our expertise focuses on phage display and technologies for therapeutic antibody discovery. IONTAS scientific staff have been at the forefront of phage display technology, mammalian display and generating antibodies against ion channels
Stabilitech has developed a proprietary technology for stabilisation of vaccines and biopharmaceuticals, removing the need for refrigeration.. . Stabilitech started research in late 2004, and received its first significant funding in 2007, from business angels. . Stabilitech has developed a novel proprietary technology which stabilizes vaccines (including live viruses, inactivated viruses and subunit vaccines), biopharmaceuticals (including antibodies, enzymes, growth factors etc) and other biological products. . Stabilitech is based in the Imperial College incubator, and currently has 5 employees.
Intellectual property services. Chartered patent and trademark attorneys, intellectual property services.. . I.P.21 combine modern customer relationship management with the delivery of the highest quality intellectual property services. We have a strong biotechnology team experienced in all phases of patent protection from drafting and filing through to prosecution. In most cases, our patent services are offered on a fixed-fee basis.. .
No data available
Isogenica partners with leading pharmaceutical and biotechnology companies in the early-stage discovery of novel biopharmaceuticals. . . Isogenica’s partners can access a range of innovative, highly-diverse, antibody libraries as an excellent starting point for new biotherapeutic development programmes.. . All the company’s libraries are fully synthetic, designed using state-of-the-art principles and built using the company’s highly precise Colibra oligonucletotide contruction technology. The combination of advanced design and accurate synthetic build technology minimises immunological biases, inevitable when using in vivo systems, and optimises the chances of generating high-affinity and developable drug candidates at the outset.. . The company’s proprietary antibody libraries are complemented with the option to use a proprietary in vitro antibody display system (CIS Display) which maintains the high diversity of the library through the discovery process. CIS Display is also available for licensing as a standalone technology.. . Isogenica currently has a range of camelid single domain antibody (VHH) libraries, and a range of human antibody fragment libraries. The company continues to innovate in the design and construction of new, advanced antibody libraries.
No data available
We are one of the largest UK and European Patent and Trade Mark Attorney firms, with offices in London, Oxford, Cambridge, Paris and Munich. The breadth and depth of our technical knowledge relevant to patents is outstanding, with over 70 science and technology graduates in the firm including over 35 PhDs. No area of science or technology is outside our scope. Our trade marks team comprises senior professionals with backgrounds in major international law firms. The team has the expertise and resources to handle any trade marks matter. . . . We draft, file and prosecute patent and trade mark applications in the UK, Europe and the rest of the world. We handle patent oppositions and appeals within Europe, especially before the European Patent Office (EPO), and we can act to protect your patents throughout the world. We assist with cases before the UK Patents Courts and provide expert support for high-profile patent litigation in the UK and elsewhere. We advise on trade mark selection and strategy and we file, defend and oppose trade mark applications in the UK, Europe and the rest of the world. We can obtain global protection for your trade marks through international applications before the World Intellectual Property Organization (WIPO) and by instructing filing and prosecution programmes worldwide. We handle all aspects of design protection in the UK, Europe and the rest of the world.
JensonR+ is a technical consultancy with a mission to promote better health by simplifying the journey from innovation to the marketplace.
Our specialist team is experienced in regulatory affairs, quality assurance and pharmacovigilance.
We know the commercial world and that speed to market and control of expenditure are critical to success.
We know that your business is unique.
We will create the optimal strategy and tailor all parameters to meet the individual and specific needs of your project.
We will work closely with you and listen to your concerns. Through a common understanding, we will help you accomplish your goals.
Our specialist team is experienced in regulatory affairs, quality assurance and pharmacovigilance.
We know the commercial world and that speed to market and control of expenditure are critical to success.
We know that your business is unique.
We will create the optimal strategy and tailor all parameters to meet the individual and specific needs of your project.
We will work closely with you and listen to your concerns. Through a common understanding, we will help you accomplish your goals.
No data available